QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
QQQ   444.67 (-0.04%)
AAPL   170.70 (-1.51%)
MSFT   421.05 (-0.09%)
META   489.25 (-0.93%)
GOOGL   150.85 (-0.01%)
AMZN   180.85 (+0.57%)
TSLA   176.85 (-1.66%)
NVDA   908.44 (+0.66%)
NIO   4.61 (-1.28%)
AMD   181.43 (+1.02%)
BABA   72.45 (+1.20%)
T   17.57 (+0.11%)
F   13.24 (+1.38%)
MU   118.28 (-0.72%)
CGC   9.28 (-2.83%)
GE   175.02 (-2.83%)
DIS   122.68 (+1.41%)
AMC   3.75 (-13.59%)
PFE   27.91 (+0.47%)
PYPL   66.84 (+0.41%)
XOM   115.46 (+0.43%)
NASDAQ:CYTR

LadRx (CYTR) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.09
$0.10
52-Week Range
N/A
Volume
4,000 shs
Average Volume
99,706 shs
Market Capitalization
$4.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
CYTR stock logo

About LadRx Stock (NASDAQ:CYTR)

LadRx Corp. is a biopharmaceutical research and development company, which engages in the discovery, research, and clinical development of novel anti-cancer drug candidates. It focuses on developing the Linker Activated Drug Release (LADR) technology platform, a discovery engine to help create a pipeline of anti-cancer molecules that will avoid unacceptable systemic toxicity while delivering highly potent agents directly to the tumor. The company was founded in 1985 and is headquartered in Los Angeles, CA.

CYTR Stock News Headlines

LadRx (LADX) Earnings Dates & Reports
Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
LadRx Corporation Announces OTCQB Ticker Change to LADX
CytRx Corporation Relaunches as LadRx Corporation
European Patent Office Awards CytRx Key Patent
Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
See More Headlines
Receive CYTR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LadRx and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:CYTR
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$4.14 million
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Stephen Snowdy
    Chief Executive Officer
  • John Y. Caloz
    Chief Financial Officer, Treasurer & Senior VP
  • Felix Kratz
    Vice President-Drug Discovery
  • Cristina Newman
    Secretary

This page (NASDAQ:CYTR) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners